Form D · Biotechnology

COAXIA INC

Maple Grove, MN · CIK 0001081070

Offering snapshot reported Mar 3, 2011 · SEC filing

Reported sold
$22.5M
Offering amount: $22.5M
Investors reported
24
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 19, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11.3M$22.5MJul 1, 2009: $17,500,000.00Jul 1, 2009Mar 3, 2011: $22,500,000.00Mar 3, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$17,500,000 → $22,500,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 3, 2011Amendment$22,500,000$5,000,000vs Jul 1, 200924SEC filing
Jul 1, 2009Initial$17,500,000No comparison24SEC filing
Apr 8, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 18, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$190K
Form D file number
021-43710

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Rockport Venture Securities, LLC113748

Source: Form D, filed Mar 3, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Brent Ahrens Director
Lorinda L. Austin Executive
Denise Barbut Director
James Bullock Director
Shelby S. Hautman Executive
B. Kristine Johnson Director
Sharon D. Kvistad Executive
Gordie Nye Director
Antoine Papiernik Director
Joshua Resnick Director
Richard S. Schallhorn Executive
Peter Shagory Director
Andrew M. Weiss Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10900 73 Rd Avenue North Suite 102
Maple Grove, MN, 55369